[HTML][HTML] Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
S Malenfant, M Lebret, É Breton-Gagnon… - European …, 2021 - Eur Respiratory Soc
Exercise intolerance is a cardinal symptom of pulmonary arterial hypertension (PAH) and
strongly impacts patients9 quality of life (QoL). Although central cardiopulmonary …
strongly impacts patients9 quality of life (QoL). Although central cardiopulmonary …
A randomized controlled trial on inspiratory muscle training in pulmonary hypertension: Effects on respiratory functions, functional exercise capacity, physical activity …
Background Impaired respiratory muscle function may be one of the causes of increased
dyspnea, reduced exercise capacity, and physical activity (PA), and poor quality of life in …
dyspnea, reduced exercise capacity, and physical activity (PA), and poor quality of life in …
[HTML][HTML] Digital tracking of physical activity, heart rate, and inhalation behavior in patients with pulmonary arterial hypertension treated with inhaled iloprost …
B Stollfuss, M Richter, D Drömann, H Klose… - Journal of Medical …, 2021 - jmir.org
Background Pulmonary arterial hypertension restricts the ability of patients to perform
routine physical activities. As part of pulmonary arterial hypertension treatment, inhaled …
routine physical activities. As part of pulmonary arterial hypertension treatment, inhaled …
[HTML][HTML] Evaluation of clinical outcomes and simultaneous digital tracking of daily physical activity, heart rate, and inhalation behavior in patients with pulmonary …
C Mueller, B Stollfuss, A Roitenberg… - JMIR Research …, 2019 - researchprotocols.org
Background: Pulmonary arterial hypertension (PAH)—a progressive, ultimately fatal disease—
patients often experience dyspnea, which can limit their daily physical activities. Iloprost is …
patients often experience dyspnea, which can limit their daily physical activities. Iloprost is …
Ikdienā integrēta un attālināti pārraudzīta fizioterapijas programma starpdisciplināras ārstēšanas pieejā pacientiem ar pulmonālo arteriālo hipertensiju. Promocijas …
L Butāne - 2023 - dspace.rsu.lv
Ievads. Pulmonālā arteriālā hipertensija (PAH) pieder reto slimību grupai, un to raksturo
progresējoša gaita ar paaugstinātu plaušu artēriju rezistenci un pieaugošu asinsspiedienu …
progresējoša gaita ar paaugstinātu plaušu artēriju rezistenci un pieaugošu asinsspiedienu …
[PDF][PDF] Hydrogen sulfide reduces skeletal muscle atrophy in pulmonary hypertension rats through Notch signaling pathway
CC Konga, FX Zhangb, AG Daic, LL Wanga - Risk, 2021 - revistaclinicapsicologica.com
Background: To explore whether hydrogen sulfide can atrophy the skeletal muscles of rats
with hypoxic pulmonary hypertension, and to explore the preliminary mechanism of action …
with hypoxic pulmonary hypertension, and to explore the preliminary mechanism of action …
A randomized controlled trial on inspiratory muscle training in pulmonary hypertension: Effects on respiratory functions, functional exercise capacity, physical activity …
Background: Impaired respiratory muscle function may be one of the causes of increased
dyspnea, reduced exercise capacity, and physical activity (PA), and poor quality of life in …
dyspnea, reduced exercise capacity, and physical activity (PA), and poor quality of life in …